Events

Servier’s recent approval of vorasidenib for Grade 2 IDH-mutant glioma has sparked renewed hope in a space that has long struggled with limited treatment options.

A dedicated forum to advancing novel radiopharmaceutical drug discovery. Delve deep into target mining, screening, discovery and selection from ROR1, uPAR, B7-H3, NECTIN-4, CAIX and more.

This year’s all-new agenda offers unprecedented detail on optimizing digital innovation, working with regulatory and legal review partners, and exploring how to establish a culture on innovation.

This symposium offers a multidisciplinary forum dedicated to navigating the forefront of operating room leadership.

The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in GI cancer treatment.

The conference dives deep into the changing world of breast cancer treatment, focusing on the latest updates for triple-negative, inflammatory, locally advanced, and metastatic breast cancers.

As the NK community remains determined as ever to prove the advantages of NK cells, the year of the ‘bounce back’ now feels within reach.

This conference is designed to enhance clinical practice to care for patients with cardiac implantable devices.

Mark your calendars and make plans to join your colleagues in San Diego, CA, from March 10–14, for AAOS 2025

The regulatory environment in the region is also developing and this annual seminar will provide an essential overview of the key requirements for product approvals for medical devices in the Middle East and North Africa.